QuantX Biosciences
PrivateLast Round
Series B
Feb 9, 2026
Total Funding Raised
$175M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QuantX Biosciences is a biotechnology company that operates a computationally driven drug discovery platform to design and optimize oral small molecule therapeutics for immune-mediated and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QuantX Biosciences Comparables
Compare QuantX Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healx | 84% | |
| Valo Health | 80% | |
| BenevolentAI | 78% |
QuantX Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 9, 2026 |
Key People
Founding team and executive leadership
QuantX Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creacion Ventures | Series A, Series B |
| OrbiMed | Series A, Series B |
| Sanofi Ventures | Series B |
| Lilly Asia Ventures | Series B |
| HongShan Capital Group (HSG) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2026
Grew 24% QoQ, from 25 to 31 employees.
- Apr 24, 2026
Grew 27% QoQ, from 22 to 28 employees.
QuantX Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about QuantX Biosciences's valuation, stock price, and market status.
Is QuantX Biosciences a public or private company?
QuantX Biosciences is a private company.
What is the current stock price of QuantX Biosciences?
QuantX Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is QuantX Biosciences worth (valuation)?
Valuation information for QuantX Biosciences is not publicly available.
Can I buy QuantX Biosciences stock?
QuantX Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was QuantX Biosciences's last funding round?
QuantX Biosciences's most recent funding round was Series B on February 9, 2026.
Who are the main investors in QuantX Biosciences?
Key investors in QuantX Biosciences include Sanofi Ventures, Lilly Asia Ventures.
Will QuantX Biosciences IPO soon?
No public IPO plans have been announced for QuantX Biosciences.
How can I track QuantX Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QuantX Biosciences's secondary market activity and sign up for updates.